Press Releases Detail

Global Single-Cell Genomics Market

avatar/IMG-10 by Foreclaro Global Research
2025 Nov, 04

According to the Foreclaro Global Research, the Global Single-Cell Genomics Market size was valued at USD 2042.7 million in 2024. The report “Global Single-Cell Genomics Market Segmentation By Product Type (Instruments {Single-cell Isolation & Dispensing Systems, Polymerase Chain Reaction (PCR) Systems, Next-Generation Sequencing (NGS) Platforms, Microarrays, High-Content Screening Systems}, Consumables {Assay Kits & Reagents, Beads & Microplates}, Software & Services), By Technology (Single-Cell RNA Sequencing (scRNA-seq), Single-Cell DNA Sequencing (scDNA-seq), Single-Cell ATAC Sequencing (scATAC-seq), Single-Cell Genome Sequencing, Single-Cell Transcriptomics, Flow Cytometry, Mass Spectrometry (CyTOF)), By Workflow (Single-Cell Isolation & Capture, Sample Preparation, Genomic Analysis, Data Analysis & Interpretation), By Application (Oncology {Tumor Heterogeneity, Cancer Genomics}, Immunology, Neurology, Stem Cell Research, Developmental Biology, Others), By End-User (Academic & Research Institutes, Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostic Laboratories, Contract Research Organizations (CROs))- Industry Trends and Forecast to 2033” gives a detailed insight into current market dynamics and provides analysis on future market growth.

 

The global Single-Cell Genomics market is witnessing strong growth driven by the increasing need to understand cellular heterogeneity and complex biological systems at the individual cell level. Advances in next-generation sequencing (NGS), microfluidics, and bioinformatics have revolutionized single-cell analysis, enabling precise insights into gene expression, disease mechanisms, and developmental biology. Growing applications in oncology, immunology, neurology, and stem cell research are fueling adoption across academic, clinical, and pharmaceutical sectors. The rising emphasis on personalized medicine and biomarker discovery further supports market expansion. Additionally, increasing government and private funding for genomics research, along with strategic partnerships among biotech companies, is accelerating innovation. However, high costs, data interpretation challenges, and the need for specialized expertise limit wider adoption. Despite these restraints, continuous technological progress and integration of multi-omics approaches are expected to drive significant growth in the single-cell genomics market over the coming years.

 

Have any questions or need more information? Click the link below to request a sample or make an inquiry before making your purchase:

https://foreclaroglobalresearch.com/research-report/global-single-cell-genomics-market

 

Global Single-Cell Genomics Market Report Highlights

·       The global single-cell genomics market is expanding rapidly due to rising demand for high-resolution cellular analysis in research and clinical applications.

·       Innovations in next-generation sequencing (NGS), microfluidics, and bioinformatics are enhancing accuracy, throughput, and accessibility of single-cell studies.

·       Major applications include oncology, immunology, neurology, stem cell research, and developmental biology, with oncology leading due to cancer heterogeneity studies.

·       Growing government and private funding, coupled with academic–industry collaborations, are accelerating genomic research and infrastructure development.

·       North America dominates the market, while Asia-Pacific is projected to witness the fastest growth owing to expanding biotechnology sectors and R&D initiatives.

·       Integration of multi-omics, spatial genomics, and AI-driven data analysis is creating new opportunities for precision medicine and clinical diagnostics.

 

Foreclaro Global Research has segmented the Single-Cell Genomics Market report based on Product Type, technology, Workflow, Application, End User Industry and region:

 

Single-Cell Genomics Market, Card Type Outlook (Revenue - USD Million, 2020 - 2033)

Instruments

·         Single-cell Isolation & Dispensing Systems

·         Polymerase Chain Reaction (PCR) Systems

·         Next-Generation Sequencing (NGS) Platforms

·         Microarrays

·         High-Content Screening Systems

Consumables

·         Assay Kits & Reagents

·         Beads & Microplates

Software & Services

 

Single-Cell Genomics Market, Technology Outlook (Revenue - USD Million, 2020 - 2033)

Single-Cell RNA Sequencing (scRNA-seq)

Single-Cell DNA Sequencing (scDNA-seq)

Single-Cell ATAC Sequencing (scATAC-seq)

Single-Cell Genome Sequencing

Single-Cell Transcriptomics

Flow Cytometry

Mass Spectrometry (CyTOF)

 

Single-Cell Genomics Market, Workflow Outlook (Revenue - USD Million, 2020 - 2033)

Single-Cell Isolation & Capture

Sample Preparation

Genomic Analysis

Data Analysis & Interpretation

 

Single-Cell Genomics Market, Application Outlook (Revenue - USD Million, 2020 - 2033)

Oncology

·         Tumor Heterogeneity

·         Cancer Genomics

Immunology

Neurology

Stem Cell Research

Developmental Biology

Others

 

Single-Cell Genomics Market, End User Outlook (Revenue - USD Million, 2020 - 2033)

Academic & Research Institutes

Biotechnology & Pharmaceutical Companies

Hospitals & Diagnostic Laboratories

Contract Research Organizations (CROs)

 

Single-Cell Genomics Market, Regional Outlook (Revenue - USD Million, 2020 - 2033)

North America

·         United States

·         Canada

·         Mexico

 

Europe

·         United Kingdom

·         Germany

·         France

·         Spain

·         Italy

·         Rest of Europe

 

Asia Pacific

·         China

·         India

·         Japan

·         Australia

·         South Korea

·         Rest of Asia Pacific

 

Latin America

·         Brazil

·         Argentina

·         Rest of Latin America

 

Middle East & Africa

·         Saudi Arabia

·         South Africa

·         Rest of MEA

 

Global Single-Cell Genomics Market Key Players

·         10x Genomics

·         Illumina, Inc.

·         Fluidigm Corporation

·         Bio-Rad Laboratories, Inc.

·         Thermo Fisher Scientific Inc.

·         BGI Genomics Co., Ltd.

·         Takara Bio, Inc.

·         NanoString Technologies, Inc.

·         QIAGEN N.V.

·         Oxford Nanopore Technologies

·         PerkinElmer, Inc.

·         Roche Sequencing Solutions